Start Date: 1/1/2024
<br />End Date: 12/31/2024
<br />Description Count How were efforts supported?Notes Additional Information & Helpful Hints about this Measure
<br /># of unique participants, who use opioids and/or have OUD, served
<br />A unique participant may participate in multiple support programs so there
<br />may be some duplication of unique participants when numbers across
<br />programs, project, sites, etc., are aggregated for the strategy-specific
<br />impact report. A participant may receive services across local government
<br />boundaries (e.g., a person with OUD may reside in one county and receive
<br />services in another county). Number of referrals do not equate to number
<br />of unique participants because one individual may receive multiple
<br />referrals.
<br /># of total contacts with all participants of the program
<br /># of participants who use opioids and/or have OUD, referred to
<br />addiction treatment
<br /># of participants who use opioids and/or have OUD, referred to
<br />recovery supports (e.g., employment services, housing services, etc.)
<br /># of participants who use opioids and/or have OUD, referred to harm
<br />reduction services (e.g., syringe and supply access, overdose
<br />prevention education, disease prevention, etc.)
<br /># of participants who use opioids and/or have OUD, referred to
<br />primary healthcare
<br /># of participants who use opioids and/or have OUD, referred to other
<br />services
<br /># of peer support specialists/care navigators
<br /># of naloxone kits distributed A naloxone kit contains two doses.
<br />Custom, strategy-specific measures may be entered in this row.
<br />Custom, strategy-specific measures may be entered in this row.
<br />Custom, strategy-specific measures may be entered in this row.
<br />Process Measure Count Additional Information & Helpful Hints about this Measure
<br /># of unique participants, who use opioids and/or have OUD, served
<br />A unique participant may participate in multiple treatment programs so
<br />there may be some duplication of unique participants when numbers
<br />across programs, project, sites, etc., are aggregated for the strategy-
<br />specific impact report. A participant may receive services across local
<br />government boundaries (e.g., a person with OUD may reside in one county
<br />and receive services in another county).
<br />American Indian/Alaska Native Non-Hispanic
<br />Asian Non-Hispanic
<br />Notes
<br />3. Recovery Support Services
<br />Insert Start and End Date for this Strategy (MM/DD/YYYY)
<br />Process measures answer the question, “How much did you do?”. Please quantify the process measures relevant to your implementation of this strategy. Indicate whether the
<br />count represents efforts supported only by opioid settlement funds or efforts supported by multiple funding sources including opioid settlement funds. Process measures
<br />should reflect numbers during the time period January 1, 2024 through December 31, 2024.
<br />STRATEGY-SPECIFIC PROCESS MEASURES
<br />DEMOGRAPHICS: Provide the following information on race and ethnicity for the # of unique participants, who use opioids and/or have OUD, served during the time period
<br />January 1, 2024 through December 31, 2024.
<br />Of the # of unique participants, who use opioids and/or have OUD, served in the count above, how many people identified as:
<br />Exhibit B: Reintegration Support Network Reporting Form
<br />Scope of Work Required Reporting. Provider must report on the approved metrics by July 15, 2024 (for Januaryl 1 - June 30), and January 15, 2025 (for July 1, 2024 - December 31, 2024). In addition to the metric reporting , provider must submit a
<br />success story (250 word limit) from a person who has benefitted from the Strategy (de-identified unless the person has agreed in writing to be identified) during the time period of January 1, 2024 through June 30, 2024, and another for the time period
<br />July 1, 2024 through December 31, 2024. These stories are to be submitted at the time of the metric reports.
<br />DocuSign Envelope ID: 3ACB2BD5-B5DB-4475-96AC-9D0A6C22362D
|